RKLB
Rocket Lab just got another thumbs-up
Roth Capital analyst Suji Desilva kept the Buy rating on Rocket Lab and bumped the price target to $100 from $90. In analyst-speak, that’s basically: “we still like the story, and we like it a little more than we did yesterday.”
Why it matters
For Rocket Lab shareholders, higher price targets can act like caffeine for a stock that already loves a little drama. It doesn’t guarantee the shares will moon, but it does signal that at least one Wall Street watcher thinks the company’s growth runway is still intact.
The bigger picture
Rocket Lab has had a noisy few days already, with legal headlines, a deal to acquire Mynaric, and the usual space-race mood swings. Add in a fresh analyst upgrade and you’ve got another piece of fuel for traders trying to figure out whether this is a true space infrastructure winner or just a very expensive rocket ride.
Big picture: when analysts start moving targets higher instead of lower, it usually means the market’s expectations are being reset upward — and that can keep momentum investors glued to the chart.